151 related articles for article (PubMed ID: 38538366)
1. [Research advances of myeloid-derived suppressor cells mediated by programmed death-1/programmed death-ligand 1 pathway in sepsis-induced immunosuppression].
Xu Y; Zang X; Chen W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Mar; 36(3):332-336. PubMed ID: 38538366
[TBL] [Abstract][Full Text] [Related]
2. Early Activation of Myeloid-Derived Suppressor Cells Participate in Sepsis-Induced Immune Suppression via PD-L1/PD-1 Axis.
Ruan WS; Feng MX; Xu J; Xu YG; Song CY; Lin LY; Li L; Lu YQ
Front Immunol; 2020; 11():1299. PubMed ID: 32719675
[No Abstract] [Full Text] [Related]
3. Melanoma Extracellular Vesicles Generate Immunosuppressive Myeloid Cells by Upregulating PD-L1 via TLR4 Signaling.
Fleming V; Hu X; Weller C; Weber R; Groth C; Riester Z; Hüser L; Sun Q; Nagibin V; Kirschning C; Bronte V; Utikal J; Altevogt P; Umansky V
Cancer Res; 2019 Sep; 79(18):4715-4728. PubMed ID: 31337655
[TBL] [Abstract][Full Text] [Related]
4. HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling.
Arkhypov I; Özbay Kurt FG; Bitsch R; Novak D; Petrova V; Lasser S; Hielscher T; Groth C; Lepper A; Hu X; Li W; Utikal J; Altevogt P; Umansky V
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36113897
[TBL] [Abstract][Full Text] [Related]
5. Granulocytic myeloid-derived suppressor cells inhibit T follicular helper cells during experimental Schistosoma japonicum infection.
Zhang Y; Wu Y; Liu H; Gong W; Hu Y; Shen Y; Cao J
Parasit Vectors; 2021 Sep; 14(1):497. PubMed ID: 34565440
[TBL] [Abstract][Full Text] [Related]
6. Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis.
Chang K; Svabek C; Vazquez-Guillamet C; Sato B; Rasche D; Wilson S; Robbins P; Ulbrandt N; Suzich J; Green J; Patera AC; Blair W; Krishnan S; Hotchkiss R
Crit Care; 2014 Jan; 18(1):R3. PubMed ID: 24387680
[TBL] [Abstract][Full Text] [Related]
7. Role of regulation of PD-1 and PD-L1 expression in sepsis.
Zhang T; Yu-Jing L; Ma T
Front Immunol; 2023; 14():1029438. PubMed ID: 36969168
[TBL] [Abstract][Full Text] [Related]
8. Polymorphonuclear Myeloid-Derived Cells That Contribute to the Immune Paralysis Are Generated in the Early Phase of Sepsis via PD-1/PD-L1 Pathway.
Ao X; Yang Y; Okiji T; Azuma M; Nagai S
Infect Immun; 2021 May; 89(6):. PubMed ID: 33753411
[TBL] [Abstract][Full Text] [Related]
9. The role of the immunosuppressive PD-1/PD-L1 checkpoint pathway in the aging process and age-related diseases.
Salminen A
J Mol Med (Berl); 2024 Jun; 102(6):733-750. PubMed ID: 38600305
[TBL] [Abstract][Full Text] [Related]
10. Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade.
Grauers Wiktorin H; Nilsson MS; Kiffin R; Sander FE; Lenox B; Rydström A; Hellstrand K; Martner A
Cancer Immunol Immunother; 2019 Feb; 68(2):163-174. PubMed ID: 30315349
[TBL] [Abstract][Full Text] [Related]
11. PD-1 signaling pathway in sepsis: Does it have a future?
Chen R; Zhou L
Clin Immunol; 2021 Aug; 229():108742. PubMed ID: 33905818
[TBL] [Abstract][Full Text] [Related]
12. Anti-PD-L1 peptide improves survival in sepsis.
Shindo Y; McDonough JS; Chang KC; Ramachandra M; Sasikumar PG; Hotchkiss RS
J Surg Res; 2017 Feb; 208():33-39. PubMed ID: 27993215
[TBL] [Abstract][Full Text] [Related]
13. The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer.
Komura N; Mabuchi S; Shimura K; Yokoi E; Kozasa K; Kuroda H; Takahashi R; Sasano T; Kawano M; Matsumoto Y; Kodama M; Hashimoto K; Sawada K; Kimura T
Cancer Immunol Immunother; 2020 Dec; 69(12):2477-2499. PubMed ID: 32561967
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive B cells expressing PD-1/PD-L1 in solid tumors: a mini review.
Sun X; Zhang T; Li M; Yin L; Xue J
QJM; 2022 Aug; 115(8):507-512. PubMed ID: 31250021
[TBL] [Abstract][Full Text] [Related]
15. Programmed Cell Death-1/Programmed Death-ligand 1 Pathway: A New Target for Sepsis.
Liu Q; Li CS
Chin Med J (Engl); 2017 Apr; 130(8):986-992. PubMed ID: 28397730
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte subset expression and serum concentrations of PD-1/PD-L1 in sepsis - pilot study.
Wilson JK; Zhao Y; Singer M; Spencer J; Shankar-Hari M
Crit Care; 2018 Apr; 22(1):95. PubMed ID: 29661225
[TBL] [Abstract][Full Text] [Related]
17. HMGB1 promotes neutrophil PD-L1 expression through TLR2 and mediates T cell apoptosis leading to immunosuppression in sepsis.
Liu J; Song K; Lin B; Chen Z; Zuo Z; Fang Y; He Q; Yao X; Liu Z; Huang Q; Guo X
Int Immunopharmacol; 2024 May; 133():112130. PubMed ID: 38648712
[TBL] [Abstract][Full Text] [Related]
18. Programmed Death-Ligand 1 Expression Potentiates the Immune Modulatory Function Of Myeloid-Derived Suppressor Cells in Systemic Lupus Erythematosus.
Park MJ; Baek JA; Choi JW; Jang SG; Kim DS; Park SH; Cho ML; Kwok SK
Front Immunol; 2021; 12():606024. PubMed ID: 33986739
[TBL] [Abstract][Full Text] [Related]
19. Increased level of myeloid-derived suppressor cells, programmed death receptor ligand 1/programmed death receptor 1, and soluble CD25 in Sokal high risk chronic myeloid leukemia.
Christiansson L; Söderlund S; Svensson E; Mustjoki S; Bengtsson M; Simonsson B; Olsson-Strömberg U; Loskog AS
PLoS One; 2013; 8(1):e55818. PubMed ID: 23383287
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients.
Zhang Y; Li J; Lou J; Zhou Y; Bo L; Zhu J; Zhu K; Wan X; Cai Z; Deng X
Crit Care; 2011; 15(1):R70. PubMed ID: 21349174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
